Aurobindo Pharma has informed that S. Subramanian, Chief Financial Officer of the Company, will be participating in virtual event of investors' meet organized by Kotak Institutional Equities on February 24,2022. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted pursuant to Regulation 30(6) of the Listing Regulations.
The above information is a part of company’s filings submitted to BSE.